Description
Composition Ibrutinib (140mg)
Substitutes Ibrucent 140mg 90s
Primary Use Mantle-cell lymphoma, Blood cancer (Chronic lymphocytic leukemia)
Medicine Overview of Imbruvica Capsule
Uses of Imbruvica Capsule
Imbruvica 140mg Capsule is used in the treatment of mantle-cell lymphoma and blood cancer (Chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy or with 17p deletion.
Imbruvica Capsule side effects
Common
Headache, Joint pain, Fever, Diarrhoea, Vomiting, Stomatitis (Inflammation of the mouth), Nausea, Constipation, Low blood platelets, Decreased white blood cell count (neutrophils), Upper respiratory tract infection.
How to use Imbruvica Capsule
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it.
How Imbruvica Capsule works
Imbruvica 140mg Capsule is a Bruton’s tyrosine kinase inhibitor. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Imbruvica Capsule related warnings
Special precautions for Imbruvica Capsule
Alcohol
There is no data available. Please consult doctor before consuming the drug.
Pregnancy
There is no data available. Please consult doctor before consuming the drug.
Lactation
There is no data available. Please consult doctor before consuming the drug.
Driving
There is no data available. Please consult doctor before consuming the drug.
Kidney
There is no data available. Please consult doctor before consuming the drug.
Liver
There is no data available. Please consult doctor before consuming the drug.
